Petra Erkens, a PhD candidate at Maastricht University in the Netherlands, participated the last four years in national and international cooperation programmes on the diagnosis and treatment of pulmonary embolism. Her main project in the Netherlands is the Amsterdam Maastricht Utrecht Study on Thromboembolism (Amuse-2). This study investigated the safety of excluding pulmonary embolism in primary care by using the Wells clinical decision rule combined with a point-of-care D-Dimer test. Furthermore, she cooperated as a clincial researcher in the Prometheus study. The Prometheus diagnostic study investigated the performance of 4 clnical decision rules in the diagnostic mangement of acute pulmonary embolism in secondary care. The Prometheus prognostic study, a prospective cohort study, is still ongoing and investigates the natural history of pulmonary embolism and assesses the degree of residual thrombo-embolic obstruction and plasma levels of markers of blood coagulation. Petra visited The Ottawa Hospital Research Institute in Canada in 2010 and conducted in collaboration with the Thrombosis Clinic of the Ottawa Hospital a retrospective cohort study on the safety of outpatient treatment in pulmonary embolism.
Presentations by Mrs. Petra Erkens currently available on MultiWebcast.com
Introduction: Pulmonary Embolism (PE) often presents with non-specific mild symptoms. A list of alternative diagnoses of PE as seen in primary care might help the primary care physician (PCP) in judging the probability of PE. This study investigated alternative diagnoses in...(more)
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
Powered by MULTIWEBCAST Technologies. MULTIWEBCAST PLATFORM Version 4.1000. All rights reserved.